Harbour Investments’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
Harbour Investments's GH Position: Q2 2026 in Review
Harbour Investments increased its Guardant Health (GH) stake by 1,400% in Q2 2026, buying an estimated $110K and bringing the position to 1,080 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #1716.
Harbour Investments first reported a position in GH in Q1 2021 and has held it in 21 quarters since. The position peaked at $340K in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Harbour Investments held 1,080 shares of Guardant Health worth $162K as of Q2 2026.
- Harbour Investments bought 1,008 Guardant Health shares in Q2 2026, an estimated $110K.
- Guardant Health made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #1716 holding.
- Harbour Investments first reported a position in Guardant Health in Q1 2021 and has held it in 21 quarters since.
- Harbour Investments's Guardant Health position peaked at $340K in Q1 2021.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.